Quick Takeaways
- 1Globe Capital LLC filed SCHEDULE 13G for Crescent Biopharma, Inc. Ordinary Shares, par value $0.001 per share (CBIO).
- Disclosed ownership: 6.4%.
- Date of event: 13 Aug 2025.
1Globe Capital LLC - 13 Aug 2025 SCHEDULE 13G Report for Crescent Biopharma, Inc. Ordinary Shares, par value $0.001 per share (CBIO)
- Filing Manager
- 1Globe Capital LLC
- Reporting Manager
- 1Globe Capital LLC
- Symbol
- CBIO
- Shares outstanding
- 13,902,512 shares
- Disclosed Ownership
- 896,712 shares
- Ownership
- 6.4%
- Form type
- SCHEDULE 13G
- Filing time
- 20 Aug 2025, 17:20:22 UTC
- Date of event
- 13 Aug 2025
- Next filing
- 14 Oct 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"1Globe Capital LLC disclosed 6.4% ownership in Crescent Biopharma, Inc. Ordinary Shares, par value $0.001 per share (CBIO) on 13 Aug 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 20 Aug 2025, 17:20.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| 1Globe Capital LLC | 6.4% | 896,712 | 0 | 896,712 | /s/ Jiaqiang Li | Chairman | |
| Jiaqiang Li | 6.4% | 896,712 | 0 | 896,712 | /s/ Jiaqiang Li | Reporting person |